Trade Pfizer ^PFE

Dividend Stocks To Research - June 13th - Markets Daily

Viral influencer: How Bill Gates' billions shape U.S. medical research

Pharmaceutical Stocks Worth Watching - June 13th - Zolmax

Insider Trading Highlights: Tesla (TSLA), Microsoft (MSFT), and Pfizer (PFE) Transactions

Pfizer (PFE) Upgraded by RBC Amid Balanced Risk-Reward Outlook

3 Stocks With a Yield Over 6% For Passive Income Investors

GLP-1s: Lilly, Novo, Pfizer look to new weight loss drugs

Van ECK Associates Corp Sells 4,813,780 Shares of Pfizer Inc. $PFE

Dr. Reddy's launches generic cancer drug Bosutinib in U.S.

Pfizer (PFE): The Best Longevity Stock to Buy Now

Pfizer Inc. $PFE Shares Sold by Cullen Capital Management LLC

Pfizer (PFE) Stock Valuation Check As Modest Recent Gains Meet Mixed Multi Year Returns

Pfizer Inc. $PFE Position Lowered by Banco Santander S.A.

State Street Corp Acquires 1,357,756 Shares of Pfizer Inc. $PFE - Daily Political

Pfizer Inc. $PFE Shares Bought by Victory Capital Management Inc. - Daily Political

Pfizer (NYSE:PFE) Cut to "Hold" at Wall Street Zen

Macquarie Group Ltd. Sells 628,927 Shares of Pfizer Inc. $PFE - Daily Political

CDC warns of COVID rebound after Paxlovid treatment

These 3 Quality Stocks Will Make You Want to LEAP on Their Calls

Dividend Stocks To Add to Your Watchlist - June 12th - Stock Observer

Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy

Kovack Advisors Inc. Increases Stake in Pfizer Inc. $PFE - Zolmax

Pfizer Inc. $PFE Shares Bought by Xponance LLC

Pfizer Inc. $PFE Shares Bought by Aviva PLC

Pfizer Inc. $PFE Stake Lowered by Swiss National Bank

Pfizer Inc. $PFE Position Boosted by Sumitomo Mitsui Financial Group Inc.

Kovack Advisors Inc. Buys 64,044 Shares of Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Sold by Logan Capital Management Inc.

Pfizer Inc. $PFE Shares Acquired by Sumitomo Mitsui Financial Group Inc. - Markets Daily

ICICI Prudential Asset Management Co Ltd Sells 198,000 Shares of Pfizer Inc. $PFE - Stock Observer

Pfizer Inc. $PFE Shares Acquired by IFM Investors Pty Ltd - Daily Political

Pfizer Inc. $PFE Stock Position Cut by Barnett & Company Inc.

Alps Advisors Inc. Sells 57,526 Shares of Pfizer Inc. $PFE

Pfizer Inc. (NYSE:PFE) Receives Consensus Rating of "Hold" from Analysts

Does New GLP‑1 Data And HYMPAVZI Expansion Reshape The Bull Case For Pfizer (PFE)?

Travere Therapeutics (TVTX) Gets a Buy from Wells Fargo

Vertex Pharmaceuticals (VRTX) Receives a Buy from Wells Fargo

Experimental human colonisation with non-toxigenic Clostridioides difficile: a placebo-controlled randomised clinical trial

Real-world cell-free circulating tumor DNA (ctDNA) analysis identifies CDK4/6 inhibitor resistance and tumor evolution in HR+ advanced breast cancer

This $25 Billion Acquisition Just Unlocked a New Era of Growth for Pfizer - and Why It's a Flawless Safe-Haven for Retirees

A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25

Pfizer (NYSE:PFE) Shares Up 2.2% - Here's What Happened - Stock Observer

Pfizer Inc. $PFE Stock Holdings Reduced by Townsquare Capital LLC - Markets Daily

Dividend Stocks To Keep An Eye On - June 11th - Daily Political

Pfizer Inc. $PFE Shares Acquired by M Holdings Securities Inc.

Pfizer Inc. $PFE Stock Position Lowered by Townsquare Capital LLC - Stock Observer

Insider Sell: Jennifer Damico Sells 2,000 Shares of Pfizer Inc (PFE)

Pfizer CEO Shakes Up Germany Investment Plans Amid Drug Pricing Controversy, ETPharma

Skeletal-muscle-targeted non-viral delivery of full-length DMD mRNA for Duchenne muscular dystrophy

Veteran Analyst Revamps Pfizer Stock Price Target for Rest of 2026

Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight

PFE Upgraded by RBC Capital -- Rating Adjusted to Sector Perform

Top Pharmaceutical Stocks To Watch Today - June 10th - Stock Observer

Here Are Wednesday's Top Wall Street Analyst Research Calls: BILL Holdings, Cava Group, Entergy, GlobalFoundries, Hess Midstream, Nike, Pfizer, SharkNinja, STMicroelectronics, and More

Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon

Cerity Partners LLC Buys 1,448,806 Shares of Pfizer Inc. $PFE

Prediction: Pfizer Stock Will Double on This Date

Pfizer's HYMPAVZI Pediatric Approval Deepens Rare Disease Growth Story

Viral Influencer: How Bill Gates' Billions Shape US Medical Research

Earn $5,000+ Yearly With These 4 Dividend Stocks

Best Pharmaceutical Stocks To Consider - June 9th - Stock Observer

Zai Lab (ZLAB) Gains Approval for Tivdak in Cervical Cancer Treatment

CenterBook Partners LP Sells 320,978 Shares of Pfizer Inc. $PFE - Zolmax

GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer

CenterBook Partners LP Lowers Position in Pfizer Inc. $PFE

Pfizer Inc. $PFE Stock Position Lessened by Commonwealth Retirement Investments LLC - Daily Political

Pfizer's Hympavzi Approved for Pediatric Hemophilia Treatment

Pfizer (NYSE:PFE) Stock Price Down 1.5% - What's Next? - Stock Observer

Promising Medical Stocks To Research - June 8th - Stock Observer

Pfizer Target of Unusually Large Options Trading (NYSE:PFE) - Daily Political

Dividend Stocks To Research - June 8th - Daily Political

Not Just a Headache: Year Three of Pfizer's OOO for Migraine Awareness Campaign Aims to Make Migraine a Visible Priority at Work

Pfizer Gets FDA Expanded Hympavzi Approval | Morningstar

US FDA approves Pfizer's bleeding disorder drug for children - Yahoo News Canada

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Inc. $PFE Stock Holdings Increased by O Shaughnessy Asset Management LLC

O Shaughnessy Asset Management LLC Has $65.26 Million Stock Position in Pfizer Inc. $PFE - Zolmax

Pfizer Inc. $PFE Holdings Lifted by Los Angeles Capital Management LLC

Pfizer Inc. $PFE Shares Purchased by Brandywine Global Investment Management LLC

Pfizer Inc. $PFE Shares Purchased by Capital World Investors - Daily Political

Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants

First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial

Pfizer presents results from Phase 2b studies of berobenatide

Top Pharmaceutical Stocks To Watch Today - June 7th - Zolmax

Pfizer (PFE) Stock Gains Ground on Once-Monthly Obesity Drug Breakthrough

Pinebridge Investments LLC Acquires New Shares in Pfizer Inc. $PFE - Zolmax

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors

Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision

Stock price forecast: 4 S&P 500 Stocks for 2025

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Week ahead: Apple earnings land as Fed seen holding rates

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk